UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 271

Sortiert nach

The Time Toxicity of Cancer Treatment

Journal of clinical oncology, 2022-05, Vol.40 (15), p.1611-1615

2022

Link zum Volltext

Verfügbarkeit prüfen

Progression-Free Survival: Meaningful or Simply Measurable?

Journal of clinical oncology, 2012-04, Vol.30 (10), p.1030-1033

2012

Link zum Volltext

Verfügbarkeit prüfen

Machine learning for modeling animal movement

PloS one, 2020-07, Vol.15 (7), p.e0235750-e0235750

2020

Link zum Volltext

Verfügbarkeit prüfen

Medical students need artificial intelligence and machine learning training

Nature biotechnology, 2021-03, Vol.39 (3), p.388-389

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group

Journal of clinical oncology, 2011-08, Vol.29 (24), p.3278-3285

2011

Link zum Volltext

Verfügbarkeit prüfen

Evolution of the Randomized Clinical Trial in the Era of Precision Oncology

JAMA oncology, 2021-05, Vol.7 (5), p.728

2021

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of Community-Engaged Research Strategies in Increasing COVID-19 Vaccinations in Targeted Communities: The Community Engagement Alliance (CEAL) Regional Teams

American journal of public health (1971), 2024-01, Vol.114 (S1), p.S124-S127

2024

Link zum Volltext

Verfügbarkeit prüfen

Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

Journal of clinical oncology, 2008-02, Vol.26 (4), p.527-534

2008

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer

Journal of clinical oncology, 2010-09, Vol.28 (27), p.4247-4254

2010

Link zum Volltext

Verfügbarkeit prüfen

Patients' attitudes and preferences toward delayed disease progression in the absence of improved survival

JNCI : Journal of the National Cancer Institute, 2023-12, Vol.115 (12), p.1526-1534

2023

Link zum Volltext

Verfügbarkeit prüfen

Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer

European journal of cancer (1990), 2023-06, Vol.186, p.52-61

2023

Link zum Volltext

Verfügbarkeit prüfen

Review of Phase II Trial Designs Used in Studies of Molecular Targeted Agents: Outcomes and Predictors of Success in Phase III

Journal of clinical oncology, 2008-03, Vol.26 (8), p.1346-1354

2008

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-21 Has Activity in Patients With Metastatic Melanoma: A Phase II Study

Journal of clinical oncology, 2012-09, Vol.30 (27), p.3396-3401

2012

Link zum Volltext

Verfügbarkeit prüfen

Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)

International journal of gynecological cancer, 2011-02, Vol.21 (2), p.419-423

2011

Link zum Volltext

Verfügbarkeit prüfen

Addition of bevacizumab to chemotherapy for treatment of solid tumors: similar results but different conclusions

Journal of clinical oncology, 2011-01, Vol.29 (3), p.254-256

2011

Link zum Volltext

Verfügbarkeit prüfen

Newborn Screening Has Moved Way Beyond PKU

Journal of obstetric, gynecologic, and neonatal nursing, 2024-05, Vol.53 (3), p.207-212

Eisenhauer, Elizabeth

2024

Link zum Volltext

Verfügbarkeit prüfen

Covid-19 Pandemic-An Opportunity to Reduce and Eliminate Low-Value Practices in Oncology?

JAMA oncology, 2020-11, Vol.6 (11), p.1693

2020

Link zum Volltext

Verfügbarkeit prüfen

Progression-free survival as an end-point in solid tumours – Perspectives from clinical trials and clinical practice

European journal of cancer (1990), 2014-09, Vol.50 (13), p.2303-2308

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of PX-866 in recurrent glioblastoma

Neuro-oncology (Charlottesville, Va.), 2015-09, Vol.17 (9), p.1270-1274

2015

Link zum Volltext

Verfügbarkeit prüfen

Primary care providers' experiences with and perceptions of personalized genomic medicine

Canadian family physician, 2016-10, Vol.62 (10), p.e626-e635

2016

Link zum Volltext

Verfügbarkeit prüfen

An interview with Dr Barbara A. Carper

Advances in nursing science, 2015-04, Vol.38 (2), p.73

Eisenhauer, Elizabeth R

2015

Link zum Volltext

Verfügbarkeit prüfen

Characterizing Variability in Lung Cancer Outcomes and Influence of a Lung Diagnostic Assessment Program in Southeastern Ontario, Canada

Current oncology (Toronto), 2023-05, Vol.30 (5), p.4880-4896

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 271

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(266)
Mit Volltextzugriff
(253)

Publikationsform

Sprache

Englisch
(271)
Japanisch
(29)

Erscheinungsjahr

n.n

Thema

Science & Technology
(188)
Life Sciences & Biomedicine
(176)
Humans
(159)
Oncology
(125)
Female
(100)
Middle Aged
(83)
Aged
(75)
Biological And Medical Sciences
(72)
Medical Sciences
(72)
Adult
(68)
Male
(64)
Pharmacology. Drug Treatments
(50)
Chemotherapy
(49)
Treatment Outcome
(46)
Tumors
(42)
Antineoplastic Agents
(41)
Antineoplastic Agents - Therapeutic Use
(37)
Aged, 80 And Over
(29)
Antineoplastic Agents - Adverse Effects
(28)
Clinical Trials
(28)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Time Toxicity of Cancer Treatment

Progression-Free Survival: Meaningful or Simply Measurable?

Machine learning for modeling animal movement

Medical students need artificial intelligence and machine learning training

Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group

Evolution of the Randomized Clinical Trial in the Era of Precision Oncology

Effectiveness of Community-Engaged Research Strategies in Increasing COVID-19 Vaccinations in Targeted Communities: The Community Engagement Alliance (CEAL) Regional Teams

Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial

Patients' attitudes and preferences toward delayed disease progression in the absence of improved survival

Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer

Review of Phase II Trial Designs Used in Studies of Molecular Targeted Agents: Outcomes and Predictors of Success in Phase III

Common Sense Oncology: outcomes that matter

Interleukin-21 Has Activity in Patients With Metastatic Melanoma: A Phase II Study

Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Addition of bevacizumab to chemotherapy for treatment of solid tumors: similar results but different conclusions

Newborn Screening Has Moved Way Beyond PKU

Covid-19 Pandemic-An Opportunity to Reduce and Eliminate Low-Value Practices in Oncology?

Progression-free survival as an end-point in solid tumours – Perspectives from clinical trials and clinical practice

Phase II study of PX-866 in recurrent glioblastoma

Primary care providers' experiences with and perceptions of personalized genomic medicine

An interview with Dr Barbara A. Carper

Characterizing Variability in Lung Cancer Outcomes and Influence of a Lung Diagnostic Assessment Program in Southeastern Ontario, Canada

Suchergebnisse filtern